Integrilin, Infusionslösung
7680540540179
CH-54054
B01AC16
06.03.2.
1 / 3
google
Details
- Product number
- 5405401
- CPT
- -
- Packaging group
- 100
- Unit
- ml
- Composition
- eptifibatidum 0.75 mg, acidum citricum monohydricum, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 1.61 mg.
Articles (1)
Integrilin, Infusionslösung
Infusionslösung
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.75 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.61 MG | Substance | HBESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 54054
- Drug name
- Integrilin, Infusionslösung
- Galenic form
- LSPA
- ATC Code
- B01AC16
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/02/1997
- Authorization expiration date
- 30/11/2025
- IT number
- 06.03.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INTEGRILIN sol inj 100 ml
- Description (DE)
- INTEGRILIN Inj Lös 100 ml
- Market launch
- 25/02/2013
- Market withdrawal
- 06/01/2025
- Narcotic (BTM)
- No